lenvatinib in renal cell carcinoma
Published 8 years ago • 546 plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
5:19
lenvatinib and cabozantinib in renal cell carcinoma
-
4:28
metastatic renal cell carcinoma: lenvatinib phase ii data
-
2:51
practical experience with lenvatinib/everolimus in rcc
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
6:42
the role of lenvatinib in advanced rcc
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
1:44
assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma
-
1:14
dr. larkin on lenvatinib plus everolimus in patients with rcc
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:32
three-arm trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
4:05
lenvatinib increases progression free survival with everolimus in metastatic renal cell carcinoma
-
7:37
lenvatinib as up-front therapy for unresectable hcc
-
1:32
phase 2 trial of lenvatinib and everolimus in metastatic renal cell carcinoma
-
1:19
phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
2:13
dr. hutson on lenvatinib/everolimus combo in rcc
-
5:32
lenvatinib and everolimus for advanced rcc
-
3:59
the future of renal cell carcinoma
-
3:42
lenvatinib and everolimus in relapsed/refractory mrcc